{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:28:23Z","timestamp":1775341703641,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010780","name":"Celltrion Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006441","name":"Center for Outcomes Research and Evaluation, Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003522","name":"Crohn's and Colitis UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003522","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>During illness, adaptations of the hypothalamic\u2013pituitary\u2010thyroid axis reduce energy expenditure, protein catabolism and modulate immune responses to promote survival. Lower serum free triiodothyronine\u2010to\u2010thyroxine (fT3\/fT4) ratio has been linked to non\u2010response to treatment in a range of diseases, including in biologic\u2010treated patients with inflammatory bowel disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To assess whether baseline serum fT3\/fT4 ratio predicted primary non\u2010response (PNR) and non\u2010remission to infliximab and adalimumab in patients with Crohn's disease<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Thyroid function tests were undertaken in stored serum from biologic\u2010na\u00efve adult patients with active luminal Crohn's disease immediately prior to treatment with infliximab (427 originator; 122 biosimilar) or adalimumab (448) in the Personalised Anti\u2010TNF Therapy in Crohn's Disease study (PANTS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Baseline median [IQR] fT3\/fT4 ratios were lower in women than men (0.30 [0.27\u20130.34] vs 0.32 [0.28\u20130.36], p\u2009&lt;\u20090.001), in patients with more severe inflammatory disease, and in patients receiving corticosteroids (0.28 [0.25\u20130.33] vs. 0.32 [0.29\u20130.36], <jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001). Multivariable logistic regression analysis demonstrated that fT3\/fT4 ratio was independently associated with PNR at week 14 (odds ratio [OR] 0.51, 95% confidence interval [CI] 0.31\u20130.85, <jats:italic>p<\/jats:italic>\u00a0=\u20090.009), but not non\u2010remission or changes in faecal calprotectin concentrations at week 54. The optimal threshold to determine PNR was 0.31 (area under the curve 0.57 [95% CI 0.54\u20130.61], sensitivity 0.62 [95% CI 0.41\u20130.74], and specificity 0.53 [95% CI 0.42\u20130.73]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Lower baseline serum fT3\/fT4 ratio was associated with female sex, corticosteroid use and disease activity. It predicted PNR to anti\u2010TNF treatment at week 14, but not non\u2010remission at week 54.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.17089","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T05:24:35Z","timestamp":1656566675000},"page":"783-793","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Understanding <scp>anti\u2010TNF<\/scp> treatment failure: does serum triiodothyronine\u2010to\u2010thyroxine (<scp>T3<\/scp>\/<scp>T4<\/scp>) ratio predict therapeutic outcome to <scp>anti\u2010TNF<\/scp> therapies in biologic\u2010na\u00efve patients with active luminal Crohn's disease?"],"prefix":"10.1111","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-4879","authenticated-orcid":false,"given":"Simeng","family":"Lin","sequence":"first","affiliation":[{"name":"Gastroenterology Royal Devon and Exeter NHS Foundation Trust  Exeter UK"},{"name":"Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-6706","authenticated-orcid":false,"given":"Neil","family":"Chanchlani","sequence":"additional","affiliation":[{"name":"Gastroenterology Royal Devon and Exeter NHS Foundation Trust  Exeter UK"},{"name":"Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Carbery","sequence":"additional","affiliation":[{"name":"Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust  Leeds UK"},{"name":"The Leeds Institute of Research at St James' University of Leeds  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Janjua","sequence":"additional","affiliation":[{"name":"Gastroenterology Royal Devon and Exeter NHS Foundation Trust  Exeter UK"},{"name":"Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Nice","sequence":"additional","affiliation":[{"name":"Biochemistry, Exeter Clinical Laboratory International Royal Devon and Exeter NHS Foundation Trust  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-6660","authenticated-orcid":false,"given":"Timothy J.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Biochemistry, Exeter Clinical Laboratory International Royal Devon and Exeter NHS Foundation Trust  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0965-9587","authenticated-orcid":false,"given":"Claire","family":"Bewshea","sequence":"additional","affiliation":[{"name":"Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-1961","authenticated-orcid":false,"given":"Nicholas A.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Gastroenterology Royal Devon and Exeter NHS Foundation Trust  Exeter UK"},{"name":"Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6058-5528","authenticated-orcid":false,"given":"Tariq","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Gastroenterology Royal Devon and Exeter NHS Foundation Trust  Exeter UK"},{"name":"Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2022-5859","authenticated-orcid":false,"given":"Christian P.","family":"Selinger","sequence":"additional","affiliation":[{"name":"Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust  Leeds UK"},{"name":"The Leeds Institute of Research at St James' University of Leeds  Leeds UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3112-376X","authenticated-orcid":false,"given":"James R.","family":"Goodhand","sequence":"additional","affiliation":[{"name":"Gastroenterology Royal Devon and Exeter NHS Foundation Trust  Exeter UK"},{"name":"Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PANTS\u00a0consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"e_1_2_11_2_1","first-page":"462","article-title":"Incidence and prevalence of inflammatory bowel disease in Devon, UK","volume":"12","author":"Hamilton B","year":"2020","journal-title":"Frontline Gastroenterol"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318936"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00225-9"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01482-4"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.01.001"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-014-0974-1"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5187061"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.10.039"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.09.039"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07674.x"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13847"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30012-3"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X17750355"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.09.041"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16167"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92767-1"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/269076"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2021-0352"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.021"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2008.09.001"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-09-0412"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2013.10.003"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2009.08.003"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.60624"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347442"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ18-0243"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091461"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.01.027"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4307"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05208-9"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.17089","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/apt.17089","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.17089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:22:47Z","timestamp":1692807767000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.17089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1111\/apt.17089"],"URL":"https:\/\/doi.org\/10.1111\/apt.17089","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"2022-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}